Philips Reaches $479 Million Settlement Over CPAP Machine Recall
Medical technology company Philips has agreed to a $479 million settlement following a recall of its Continuous Positive Airway Pressure (CPAP) machines. The settlement was reached in response to a class-action lawsuit filed by users of the affected devices.
The recall, announced in June 2021, involved approximately three to four million CPAP and Bi-Level Positive Airway Pressure (Bi-Level PAP) machines. These devices are commonly used to treat sleep apnea, a condition that causes interrupted breathing during sleep.
The recall was prompted by concerns over potential health risks associated with the sound abatement foam used in the devices. It was discovered that this foam could degrade over time, releasing harmful particles and gases into the air pathway of the machines, which users then breathe in.
According to Philips, the risk of exposure to these particles and gases is low, but the company decided to take action to ensure patient safety. The affected devices were manufactured between 2009 and April 26, 2021.
The settlement will provide compensation to individuals who experienced issues with their CPAP or Bi-Level PAP machines. It covers the cost of repair or replacement of the devices, as well as any necessary medical treatment resulting from the use of the affected machines.
In addition to the financial settlement, Philips has also committed to providing updated instructions and labeling for affected devices, as well as offering a program to monitor and address any potential health risks associated with the foam degradation.
The settlement agreement is subject to court approval and will cover users in the United States who purchased or used the affected devices. Individuals will have the opportunity to participate in the settlement by submitting claims once it is approved.
Philips has expressed its commitment to resolving the issue and ensuring the safety of its customers. The company has set up a dedicated website and customer support line to provide information and assistance to affected users.
It is important for individuals who use CPAP or Bi-Level PAP machines to be aware of the recall and take appropriate action. Users should consult with their healthcare providers and follow the instructions provided by Philips to ensure their safety and well-being.
The settlement represents a significant step towards addressing the concerns raised by the CPAP machine recall. Philips’ willingness to compensate affected users and implement measures to mitigate potential health risks demonstrates its commitment to customer satisfaction and safety in the medical device industry.
